Yohan Desbrosses

463 total citations
8 papers, 43 citations indexed

About

Yohan Desbrosses is a scholar working on Hematology, Oncology and Epidemiology. According to data from OpenAlex, Yohan Desbrosses has authored 8 papers receiving a total of 43 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Hematology, 2 papers in Oncology and 2 papers in Epidemiology. Recurrent topics in Yohan Desbrosses's work include Acute Myeloid Leukemia Research (3 papers), Fungal Infections and Studies (2 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (1 paper). Yohan Desbrosses is often cited by papers focused on Acute Myeloid Leukemia Research (3 papers), Fungal Infections and Studies (2 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (1 paper). Yohan Desbrosses collaborates with scholars based in France and Belgium. Yohan Desbrosses's co-authors include Ana Berceanu, Étienne Daguindau, Éric Deconinck, Christophe Ferrand, Marina Deschamps, Walid Warda, Xavier Roussel, Patrice Muret, Bénedicte Bruno and Frédéric Grenouillet and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Frontiers in Oncology.

In The Last Decade

Yohan Desbrosses

7 papers receiving 40 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yohan Desbrosses France 5 20 15 13 8 7 8 43
M Rovira Spain 4 17 0.8× 30 2.0× 16 1.2× 9 1.1× 4 0.6× 12 69
Mike Halpenny Canada 6 31 1.6× 17 1.1× 12 0.9× 3 0.4× 8 1.1× 10 65
Sebastián Galeano Uruguay 5 20 1.0× 6 0.4× 23 1.8× 4 0.5× 12 1.7× 10 52
Ana Gorosquieta Spain 4 22 1.1× 27 1.8× 8 0.6× 8 1.0× 10 1.4× 9 58
Anne Daguenel France 4 13 0.7× 13 0.9× 8 0.6× 6 0.8× 2 0.3× 4 43
Khushnuma Mullanfiroze India 3 11 0.6× 11 0.7× 31 2.4× 5 0.6× 3 0.4× 10 40
Katharina L. Gössling Germany 4 6 0.3× 21 1.4× 11 0.8× 10 1.3× 7 1.0× 5 41
Е. Г. Хамаганова Russia 4 13 0.7× 8 0.5× 7 0.5× 8 1.0× 2 0.3× 33 52
Valle Gómez Spain 4 46 2.3× 9 0.6× 9 0.7× 7 0.9× 6 0.9× 6 57
Martha Margarita Velázquez‐Aviña Mexico 3 7 0.3× 13 0.9× 10 0.8× 8 1.0× 10 1.4× 5 32

Countries citing papers authored by Yohan Desbrosses

Since Specialization
Citations

This map shows the geographic impact of Yohan Desbrosses's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yohan Desbrosses with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yohan Desbrosses more than expected).

Fields of papers citing papers by Yohan Desbrosses

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yohan Desbrosses. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yohan Desbrosses. The network helps show where Yohan Desbrosses may publish in the future.

Co-authorship network of co-authors of Yohan Desbrosses

This figure shows the co-authorship network connecting the top 25 collaborators of Yohan Desbrosses. A scholar is included among the top collaborators of Yohan Desbrosses based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yohan Desbrosses. Yohan Desbrosses is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Orvain, Corentin, Sarah Bertoli, Pierre Péterlin, et al.. (2023). Molecular Relapse after First-Line Intensive Therapy in Patients with Core-Binding Factor and NPM1-Mutated Acute Myeloid Leukemia - a Filo Study. Blood. 142(Supplement 1). 421–421.
2.
Magro, Léonardo, Tamim Alsuliman, Patrice Céballos, et al.. (2022). La cystite hémorragique après allogreffe de cellules souches hématopoïétiques : prophylaxie, diagnostic, et traitement. Recommandations de la SFGM-TC. Bulletin du Cancer. 110(2). S48–S55. 2 indexed citations
3.
Roussel, Xavier, Étienne Daguindau, Ana Berceanu, et al.. (2020). Acute Myeloid Leukemia: From Biology to Clinical Practices Through Development and Pre-Clinical Therapeutics. Frontiers in Oncology. 10. 599933–599933. 16 indexed citations
4.
Berceanu, Ana, Éric Deconinck, Étienne Daguindau, et al.. (2020). Arsenic Trioxide Treatment during Pregnancy for Acute Promyelocytic Leukemia in a 22-Year-Old Woman. SHILAP Revista de lepidopterología. 2020. 1–5. 6 indexed citations
5.
Roussel, Xavier, Étienne Daguindau, Ana Berceanu, et al.. (2019). Altered thymic CD4+ T-cell recovery after allogeneic hematopoietic stem cell transplantation is critical for nocardiosis. Current Research in Translational Medicine. 67(4). 135–143. 4 indexed citations
7.
Desbrosses, Yohan, et al.. (2019). Suivi des donneurs apparentés : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). Bulletin du Cancer. 107(1). S94–S103. 3 indexed citations
8.
Grenouillet, Frédéric, Étienne Daguindau, Patrice Muret, et al.. (2014). Posaconazole prophylaxis in neutropenic patients with hematological malignancies: limits in clinical practice. Medical Mycology. 52(7). 728–735. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026